Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Apr;52(3):975-83.
doi: 10.1007/s00394-012-0404-7. Epub 2012 Jul 6.

Effects of L-arginine Supplementation on Blood Flow, Oxidative Stress Status and Exercise Responses in Young Adults With Uncomplicated Type I Diabetes

Randomized Controlled Trial

Effects of L-arginine Supplementation on Blood Flow, Oxidative Stress Status and Exercise Responses in Young Adults With Uncomplicated Type I Diabetes

Ana Paula Trussardi Fayh et al. Eur J Nutr. .


Background and aims: Vascular disease is the principal cause of death and disability in patients with diabetes, and endothelial dysfunction seems to be the major cause in its pathogenesis. Since L-arginine levels are diminished in conditions such as type 1 and type 2 diabetes, in this work we aimed to verify the effects of L-arginine supplementation (7 g/day) over the endothelial function and oxidative stress markers in young male adults with uncomplicated type 1 diabetes. We also investigated the influences of L-arginine administration on vascular/oxidative stress responses to an acute bout of exercise.

Methods: Ten young adult male subjects with uncomplicated type 1 diabetes and twenty matched controls volunteered for this study. We analysed the influence of L-arginine supplementation (7 g/day during 1 week) over lower limb blood flow (using a venous occlusion plethysmography technique), oxidative stress marker (TBARS, Carbonyls), anti-oxidant parameters (uric acid and TRAP) and total tNOx in rest conditions and after a single bout of submaximal exercise (VO₂ at 10 % below the second ventilatory threshold). Data described as mean ± standard error (SE). Alpha level was P < 0.05.

Results: Glycaemic control parameters were altered in type 1 diabetic subjects, such as HbA1c (5.5 ± 0.03 vs. 8.3 ± 0.4 %) and fasted glycaemia (94.8 ± 1.4 vs. 183 ± 19 mg/dL). Oxidative stress/damage markers (carbonyls and TBARS) were increased in the diabetic group, while uric acid was decreased. Rest lower limb blood flow was lower in type 1 diabetic subjects than in healthy controls (3.53 ± 0.35 vs. 2.66 ± 0.3 ml 100 ml⁻¹ min⁻¹). L-Arginine supplementation completely recovered basal blood flow to normal levels in type 1 diabetics' subjects (2.66 ± 0.3 to 4.74 ± 0.86 ml 100 ml⁻¹ min⁻¹) but did not interfere in any parameter of redox state or exercise.

Conclusion: Our findings highlight the importance of L-arginine for the improvement of vascular function in subjects with diabetes, indicating that L-arginine supplementation could be an essential tool for the treatment for the disease complications, at least in non-complicated diabetes. However, based on our data, it is not possible to draw conclusions regarding the mechanisms by which L-arginine therapy is inducing improvements on cardiovascular function, but this important issue requires further investigations.

Similar articles

See all similar articles

Cited by 8 articles

See all "Cited by" articles


    1. Nitric Oxide. 2002 Mar;6(2):101-24 - PubMed
    1. Diabetes Care. 2008 May;31(5):940-4 - PubMed
    1. Am J Cardiol. 1990 May 1;65(16):1127-33 - PubMed
    1. Diabetologia. 2002 Nov;45(11):1515-22 - PubMed
    1. Cardiovasc Res. 1985 Mar;19(3):177-80 - PubMed

Publication types

MeSH terms

LinkOut - more resources